DUBLIN–(BUSINESS WIRE)– Research and Markets ( ) has voiced the add-on of iCD Research’s new firm form ” Dermalogica, Inc.: Company Profile and SWOT Analysis ” to their offering.
Dermalogica, Inc. (Dermalogica) is a war paint company. It engages in production and selling skin caring products. Dermalogica serves consumers and skin caring professionals by skin treatment centers, salons and spas in the US and internationally. The company’s product portfolio comprises moisturizers, shampoos, toners, cleansers, exfoliants and conditioners. Its products network moreover includes UltraCalming, skin health, AGE smart, body therapy, daytime defense, shave, mediBac open space and ChromaWhite TRx. These products are offering by over 75,000 competent skin caring professionals in 48 countries worldwide. The firm has leading operations in the US, the UK, Australia, Ireland, and Canada. Dermalogica is headquartered in Carson, California, the US.
Synopsis
ICD Research’s ” Dermalogica, Inc.: Company Profile and SWOT Analysis ” contains in height data and data about the firm and its operations. The form contains a firm overview, business description, SWOT analysis, key facts, data on products and services, sum of locations and subsidiaries, in addition to data on key headlines events inspiring the company.
Summary
This SWOT review and firm form is a major resource for attention management team and any person seeking to earn a improved bargain of the company’s business.
Reasons To Buy
Quickly complement your bargain of the firm
Gain perception in to the marketplace and a improved bargain of inner and outmost factors that could repercussions the attention
Increase business/sales actions by bargain your competitors’ businesses improved
Recognize future partnerships and suppliers
No comments:
Post a Comment